Publications by authors named "Neil Moss"

Claim this Profile
D
Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
Kenneth Meyers, Derek A Cogan, Jennifer Burke, Raquel Arenas, Michael Balestra, Neil Moss

Bioorg Med Chem Lett· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Arylsulfonyl-α-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity.
Asitha Abeywardane, Gary Caviness, Younggi Choi, Derek Cogan, Amy Gao, Neil Moss

Bioorg Med Chem Lett· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectivity of BI 689648, a Novel, Highly Selective Aldosterone Synthase Inhibitor: Comparison with FAD286 and LCI699 in Nonhuman Primates.
Steven M Weldon, Matthew A Cerny, Kristina Gueneva-Boucheva, Derek Cogan, Xin Guo, Neil Moss

J Pharmacol Exp Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of cathepsin S inhibitors characterized by a triazole P1-P2 amide replacement.
Neil Moss, Zhaoming Xiong, Mike Burke, Derek Cogan, Donghong A Gao

Bioorg Med Chem Lett· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.
Donghong Amy Gao, Zhaoming Xiong, Alexander Heim-Riether, Laura Amodeo, E Michael August, Neil Moss

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.
Alexander Heim-Riether, Steven J Taylor, Shuang Liang, Donghong Amy Gao, Zhaoming Xiong, Neil Moss

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitors.
Pier F Cirillo, Eugene R Hickey, Neil Moss, Steffen Breitfelder, Raj Betageri

Bioorg Med Chem Lett· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties.
Neil Moss, Younggi Choi, Derek Cogan, Adam Flegg, Andreas Kahrs

Bioorg Med Chem Lett· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR studies of indole-based MK2 inhibitors.
Zhaoming Xiong, Donghong Amy Gao, Derek A Cogan, Daniel R Goldberg, Ming-Hong Hao, Neil Moss

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New modifications to the area of pyrazole-naphthyl urea based p38 MAP kinase inhibitors that bind to the adenine/ATP site.
Neil Moss, Steffen Breitfelder, Raj Betageri, Pier F Cirillo, Tazmeen Fadra

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of carboline analogs as potent MAPKAP-K2 inhibitors.
Jiang-Ping Wu, Ji Wang, Asitha Abeywardane, Denise Andersen, Michel Emmanuel, Neil Moss

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of p38 inhibitors via computer-assisted drug design.
Daniel R Goldberg, Ming-Hong Hao, Kevin C Qian, Alan D Swinamer, Donghong A Gao, Neil Moss

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
Hiroshi Yasui, Teru Hideshima, Hiroshi Ikeda, Janice Jin, Enrique M Ocio, Neil Moss

Br J Haematol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase.
Abdelhakim Hammach, Antonio Barbosa, Faith Corbo Gaenzler, Tazmeen Fadra, Daniel Goldberg, Neil Moss

Bioorg Med Chem Lett· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of the p38alpha MAP kinase inhibitor 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796).
John Regan, Alison Capolino, Pier F Cirillo, Thomas Gilmore, Anne G Graham, Neil Moss

J Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The kinetics of binding to p38MAP kinase by analogues of BIRB 796.
John Regan, Christopher A Pargellis, Pier F Cirillo, Thomas Gilmore, Eugene R Hickey, Neil Moss

Bioorg Med Chem Lett· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones: orally active inhibitors of lck kinase.
Daniel R Goldberg, Tanja Butz, Mario G Cardozo, Robert J Eckner, Abdelhakim Hammach, Neil Moss

J Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2-phenylamino-imidazo[4,5-h]isoquinolin-9-ones: a new class of inhibitors of lck kinase.
Roger J Snow, Mario G Cardozo, Tina M Morwick, Carl A Busacca, Yong Dong, Neil Moss

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.
John Regan, Steffen Breitfelder, Pier Cirillo, Thomas Gilmore, Anne G Graham, Neil Moss

J Med Chem· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.
Christopher Pargellis, Liang Tong, Laurie Churchill, Pier F Cirillo, Thomas Gilmore, Neil Moss

Nat Struct Biol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Practical and Diastereoselective Synthesis of Ketomethylene Dipeptide Isosteres of the Type AAPsi[COCH(2)]Asp.
Robert Déziel, Raymond Plante, Valérie Caron, Louis Grenier, Montse Llinas-Brunet, Neil Moss

J Org Chem· April 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis